Rituximab Administration and Reactivation of HBV
Joint Authors
Ito, Shinichi
Tanaka, Junji
Asaka, Masahiro
Yamamoto, Yoshiya
Tsutsumi, Yutaka
Ogasawara, Reiki
Kamihara, Yusuke
Imamura, Masahiro
Source
Hepatitis Research and Treatment
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-12-01
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Rituximab is a drug used for the treatment of B-cell non-Hodgkin's lymphoma, and its range of use has expanded to the treatment of collagen diseases such as idiopathic thrombocytopenic purpura and rheumatoid arthritis.
One serious complication of rituximab use is the reactivation of dormant hepatitis B virus, and prevention of this phenomenon has become an urgent issue.
This paper provides a general outline of the problem through an analysis of patient cases that we and other groups have experienced to date.
American Psychological Association (APA)
Tsutsumi, Yutaka& Ogasawara, Reiki& Kamihara, Yusuke& Ito, Shinichi& Yamamoto, Yoshiya& Tanaka, Junji…[et al.]. 2010. Rituximab Administration and Reactivation of HBV. Hepatitis Research and Treatment،Vol. 2010, no. 2010, pp.1-8.
https://search.emarefa.net/detail/BIM-452478
Modern Language Association (MLA)
Tsutsumi, Yutaka…[et al.]. Rituximab Administration and Reactivation of HBV. Hepatitis Research and Treatment No. 2010 (2010), pp.1-8.
https://search.emarefa.net/detail/BIM-452478
American Medical Association (AMA)
Tsutsumi, Yutaka& Ogasawara, Reiki& Kamihara, Yusuke& Ito, Shinichi& Yamamoto, Yoshiya& Tanaka, Junji…[et al.]. Rituximab Administration and Reactivation of HBV. Hepatitis Research and Treatment. 2010. Vol. 2010, no. 2010, pp.1-8.
https://search.emarefa.net/detail/BIM-452478
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-452478
